Synthetic & Augmented Data

Synthetic Medical Records

MDClone-style synthetic EHR data — privacy-preserving medical training data.

No listings currently in the marketplace for Synthetic Medical Records.

Find Me This Data →

Overview

What Is Synthetic Medical Records?

Synthetic medical records are artificial patient-level datasets that statistically replicate real clinical information while containing no identifiable patient details. These privacy-preserving datasets enable healthcare organizations to develop, test, and validate new technologies without legal or ethical concerns tied to actual patient records. By mimicking real-world data patterns from electronic health records, synthetic medical datasets allow teams to build machine learning models, train algorithms, and simulate clinical workflows in secure environments while remaining fully compliant with privacy regulations like HIPAA. The technology removes access barriers to restricted data and accelerates innovation cycles across clinical informatics, data science, and digital health teams.

Market Data

US$500.32 Million

Global Synthetic Data in Healthcare Market (2024)

Source: DataM Intelligence

US$5.88 Billion

Projected Market Size (2033)

Source: DataM Intelligence

31.5% CAGR

Market Growth Rate (2026–2033)

Source: DataM Intelligence

96%

U.S. Hospitals with Certified EHRs

Source: DataM Intelligence

71%

U.S. Hospitals Using Predictive AI in EHRs (2024)

Source: DataM Intelligence

Who Uses This Data

What AI models do with it.do with it.

01

Machine Learning Model Development

Data science teams use synthetic medical records to train and validate AI algorithms without accessing restricted real patient data, accelerating model development cycles.

02

Clinical Trial Simulation & Feasibility Assessment

Pharmaceutical and biotech companies leverage synthetic patient cohorts to simulate trial outcomes, test enrollment strategies, and assess trial feasibility before launching actual studies.

03

Healthcare IT & Digital Workflow Testing

Clinical informatics, IT, and digital innovation teams use synthetic datasets to test new EHR features, algorithms, and workflows in realistic conditions while maintaining compliance and data security.

04

Staff Training & Education

Healthcare organizations deploy synthetic records to train clinical staff, data analysts, and IT personnel on new systems and protocols using realistic but privacy-safe scenarios.

What Can You Earn?

What it's worth.worth.

Synthetic Medical Data Generation Platforms Market

Varies

Market valued at USD 318 million in 2025, expected to reach USD 2.18 billion by 2036, indicating substantial enterprise pricing across platform tiers.

Synthetic Clinical Trial Data Market

Varies

Market sized at USD 96.5 million in 2026, projected to reach USD 518.1 million by 2036, reflecting significant demand from pharmaceutical and CRO buyers.

What Buyers Expect

What makes it valuable.valuable.

01

Statistical Realism

Synthetic records must accurately reflect real-world clinical data patterns, including distributions, correlations, and edge cases found in actual patient populations, to ensure model validity.

02

Privacy Compliance & De-identification

Data must contain no personally identifiable information and meet HIPAA, GDPR, and other regulatory standards while maintaining utility for downstream analytics and machine learning.

03

Longitudinal & Multimodal Support

Buyers increasingly expect synthetic datasets that support longitudinal patient records, imaging-linked data, and multimodal records across structured, unstructured, and semi-structured formats.

04

Scalability & Customization

Platforms must generate large-scale synthetic cohorts tailored to specific use cases—clinical trials, drug discovery, patient management—with flexible deployment options (cloud, on-premises, hybrid).

Companies Active Here

Who's buying.buying.

Pharmaceutical & Biotechnology Companies

Clinical trial simulation, synthetic control arms, feasibility assessment, drug discovery model training, and regulatory submissions using realistic patient cohorts.

Contract Research Organizations (CROs)

Synthetic patient populations for trial design, recruitment strategy validation, endpoint modeling, and multi-trial data pooling without privacy exposure.

Healthcare Systems & Hospitals

EHR algorithm testing, clinical workflow simulation, AI model validation, staff training, and digital innovation piloting using realistic yet privacy-safe datasets.

Academic & Research Institutions

Medical informatics research, epidemiological studies, health services research, and AI/ML algorithm development using large-scale synthetic cohorts.

FAQ

Common questions.questions.

How do synthetic medical records differ from real patient data?

Synthetic medical records are artificially generated datasets that statistically replicate patterns found in real clinical data but contain no actual patient identifiers. They preserve data utility for research and analytics while eliminating privacy risks and regulatory compliance burdens associated with real health records.

Why is the synthetic medical data market growing so rapidly?

The market is expanding at 31.5% CAGR through 2033 due to the widespread adoption of certified EHRs (96% of U.S. non-federal acute care hospitals), increasing use of predictive AI in healthcare settings (71% of U.S. hospitals in 2024), and growing regulatory pressure to protect patient privacy while enabling data-driven innovation.

Which industries buy synthetic medical records most?

Pharmaceutical and biotech companies, contract research organizations, healthcare systems, and academic medical centers are the primary buyers. They use synthetic records for clinical trial simulation, AI model development, workflow testing, and research without privacy exposure.

What quality standards should synthetic medical data meet?

Buyers expect statistical realism that mirrors actual clinical patterns, full HIPAA and privacy compliance with no identifiable information, support for longitudinal and multimodal data formats, and flexible scalability across cloud, on-premises, and hybrid deployments tailored to specific use cases like drug discovery and clinical trials.

Sell yoursynthetic medical recordsdata.

If your company generates synthetic medical records, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.

Request Valuation